Skip to content

chronic non-cancer pain

opioid pain medications

Study:  Are Prescription Opioids Driving the Opioid Crisis? Assumptions vs Facts

Many current assumptions about opioid analgesics are ill-founded. Illicit fentanyl and heroin, not opioid prescribing, now fuel the current opioid overdose epidemic. National discussion has often neglected the potentially devastating effects of uncontrolled chronic pain. Opioid analgesic prescribing and related overdoses are in decline, at great cost to patients with pain who have benefited or may benefit from, but cannot access, opioid analgesic therapy.

UNSW Sydney

GUIDELINE FOR DEPRESCRIBING OPIOID ANALGESICS

This is important for every Australian who is on long-term opioid therapy for chronic pain https://www.opioiddeprescribingguideline.com Most people in the chronic pain community will not be aware that there are Draft Opioid Deprescribing Guidelines currently open for public comment. The Draft Guidelines and a template… Read More »GUIDELINE FOR DEPRESCRIBING OPIOID ANALGESICS

opioid pain medication

Study: “One Size Fits All” Doesn’t Fit When It Comes to Long-Term Opioid Use for People with Chronic Pain

M. E. Lynch &J. KatzPublished online: 04 May 2017 Information courtesy of Kev James, Chronic Pain Patient Advocate. LinkedIn Source: https://www.tandfonline.com/doi/full/10.1080/24740527.2017.1319733 This study pulls no punches: “The use of opioids in chronic non-cancer pain continues to be a flashpoint in medicine. The media and others… Read More »Study: “One Size Fits All” Doesn’t Fit When It Comes to Long-Term Opioid Use for People with Chronic Pain

opioid pain medication

Study: Appropriate and responsible use of opioids in chronic non-cancer pain

Harald Breivik First published: 09 January 2012 Information courtesy of Kev James, Chronic Pain Patient Advocate. LinkedIn Read the full study here In 2012 a group of distinguished pain clinicians from nine European countries got together to discuss the appropriate use of strong opioids for… Read More »Study: Appropriate and responsible use of opioids in chronic non-cancer pain

opioid pain medication

Study: Long-term use of controlled-release oxycodone for noncancer pain: results of a 3-year registry study

After three months of treatment, the large majority of patients, who were on stable doses, the average pain intensity scores were  unchanged or improved for approximately 70 to 80% of patients.  The most common adverse events were not serious, including constipation and nausea, and the incidence of these events declined over time on treatment. 

UNSW Sydney

New UNSW report: Problem opioid behaviours are related to pre-existing risks, not dose

A new study from UNSW Sydney has analysed findings from a five-year cohort of 1514 people who have been prescribed opioids for chronic non-cancer pain, finding that risk for problematic opioid outcomes is related to a combination of patient characteristics and pre-existing factors, rather than… Read More »New UNSW report: Problem opioid behaviours are related to pre-existing risks, not dose